Baseline circulating soluble factors as predictors of response to nivolumab in metastatic clear cell renal cell carcinoma (mRCC): A validation study within the NIVOREN GETUG-AFU 26 translational study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results